Unknown PHASE1 INTERVENTIONAL 2-arm NCT02565459

MSC and Kidney Transplant Tolerance (Phase A)

Third-party Bone Marrow-derived Mesenchymal Stromal Cells to Induce Tolerance in Recipients of Kidney Transplants From Deceased Donors (Phase A)

Sponsor: Mario Negri Institute for Pharmacological Research

Conditions Chronic Renal Failure

Interventions Mesenchymal Stromal Cells

Updated 6 times since 2017 Last updated: Apr 5, 2018 Started: Sep 30, 2015 Primary completion: Sep 30, 2021 Completion: Dec 31, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Chronic Renal Failure and is currently ongoing. Mario Negri Institute for Pharmacological Research leads this study, which shows 6 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Mar 2022 — Jul 2024 [monthly]

Unknown Status PHASE1

Status: Recruiting → Unknown Status
Jan 2021 — Mar 2022 [monthly]

Recruiting PHASE1
Jun 2018 — Jan 2021 [monthly]

Recruiting PHASE1

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Recruiting PHASE1

First recorded

Sep 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mario Negri Institute for Pharmacological Research
Monia Lorini

Data source: A.O. Ospedale Papa Giovanni XXIII

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bergamo, Italy